Retrospective Comparison of the Amplatz Thrombectomy Device with Modified Pulse-Spray Pharmacomechanical Thrombolysis in the Treatment of Thrombosed Hemodialysis Access Grafts

Sofocleous, Constantinos T.; Cooper, Stanley G.; Schur, Israel; Patel, R.; Iqbal, Azher; Walker, Sidney P.

doi:10.1148/radiology.213.2.r99nv32561

Cited by 51 publications

(20 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, owing to follow-up limitations in the study period, we only had 1-and 3-month data available at the time of writing. Our 1-and 3-month primary patency rates of 81.1% and 63.6% are comparable to previous published studies (18)(19)(20)(21).…”

Section: Procedural Resultssupporting

confidence: 91%

Novel use of the ClariVein® Catheter for Pharmacomechanical Thrombolysis of Thrombosed Hemodialysis Grafts: A Case Series

Lim

Chen

et al. 2017

J Vasc Access

View full text Add to dashboard Cite

Introduction The aim of this prospectively collected case series is to demonstrate a novel technique of using the ClariVein® catheter for pharmacomechanical thrombolysis of thrombosed hemodialysis grafts. Methods The analysis comprised 11 procedures in 9 patients from 1 July to 31 December 2016 in which the ClariVein catheter was used in combination with urokinase. Demographic data, procedural data, technical and clinical success rates, and complications were evaluated. The primary and secondary patency rates at 1 and 3 months were also analyzed. Results In the 11 procedures performed, the technical and clinical success was 100%. The mean procedural time was 66.8 minutes (range 50-90 minutes), and the mean amount of urokinase administered was 87,000 units. The primary unassisted patency rates at 1 and 3 months were 81.8% and 63.6%, respectively. The secondary patency rates at 1 and 3 months were 90.9% and 81.8%, respectively. Perforation occurred after balloon angioplasty in 1 (9.1%) of the 11 procedures, for which covered stenting was performed. No major complications occurred. Conclusions The combination use of the ClariVein catheter with urokinase for pharmacomechanical thrombolysis in thrombosed hemodialysis grafts is a feasible and safe method that can be performed in a relatively short duration. Our early results have shown 100% technical and clinical success. This case series serves as a platform for an upcoming prospective study to further evaluate this method.

show abstract

Section: Procedural Resultssupporting

confidence: 91%

Novel use of the ClariVein® Catheter for Pharmacomechanical Thrombolysis of Thrombosed Hemodialysis Grafts: A Case Series

Lim

Chen

et al. 2017

J Vasc Access

View full text Add to dashboard Cite

show abstract

“…In the current series an arterial embolus was diagnosed in 0.38% of the cases; the percentage of these that were symptomatic was not recorded. Table 3 compares the complications that have been reported in the literature [40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57] with those seen in this study.…”

Section: Discussionmentioning

confidence: 99%

Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists

Beathard¹,

Litchfield²

2004

Kidney International

152

130

View full text Add to dashboard Cite

show abstract

“…They also found that most complications encountered during percutaneous thrombolysis or surgical thrombectomy of thrombosed prosthetic access could be treated at the same sitting, allowing the same access to be used for hemodialysis. 114 Percutaneous excimer laser-facilitated thrombus vaporization is also found to be safe and effective for recanalization of acute and subacute thrombotic occlusions of hemodialysis shunts. 115 1.…”

Section: Poor Venous Outflowmentioning

confidence: 99%

The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access

Sidawy

Spergel

Besarab

et al. 2008

Journal of Vascular Surgery

466

411

View full text Add to dashboard Cite

Recognizing the impact of the decision making by the dialysis access surgeon on the successful placement of autogenous arteriovenous hemodialysis access, the Society for Vascular Surgery assembled a multispecialty panel to develop practice guidelines in arteriovenous access placement and maintenance with the aim of maximizing the percentage and functionality of autogenous arteriovenous accesses that are placed. The Society commissioned the Knowledge and Encounter Research Unit of the Mayo Clinic College of Medicine, Rochester, Minnesota, to systematically review the available evidence in three main areas provided by the panel: timing of referral to access surgeons, type of access placed, and effectiveness of surveillance. The panel then formulated practice guidelines in seven areas: timing of referral to the access surgeon, operative strategies to maximize the placement of autogenous arteriovenous accesses, first choice for the autogenous access, choice of arteriovenous access when a patient is not a suitable candidate for a forearm autogenous access, the role of monitoring and surveillance in arteriovenous access management, conversion of a prosthetic arteriovenous access to a secondary autogenous arteriovenous access, and management of the nonfunctional or failed arteriovenous access. For each of the guidelines, the panel stated the recommendation or suggestion, discussed the evidence or opinion upon which the recommendation or suggestion was made, detailed the values and preferences that influenced the group's decision in formulating the relevant guideline, and discussed technical remarks related to the particular guideline. In addition, detailed information is provided on various configurations of autogenous and prosthetic accesses and technical tips related to their placement.

show abstract

Retrospective Comparison of the Amplatz Thrombectomy Device with Modified Pulse-Spray Pharmacomechanical Thrombolysis in the Treatment of Thrombosed Hemodialysis Access Grafts

Cited by 51 publications

References 22 publications

Novel use of the ClariVein® Catheter for Pharmacomechanical Thrombolysis of Thrombosed Hemodialysis Grafts: A Case Series

Novel use of the ClariVein® Catheter for Pharmacomechanical Thrombolysis of Thrombosed Hemodialysis Grafts: A Case Series

Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists

The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access

Contact Info

Product

Resources

About